Trials / Conditions / Hookworm Infection

Hookworm Infection

20 registered clinical trials studyying Hookworm Infection — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Efficacy and Safety of Emodepside in Participants With Soil-transmitted Helminth Infections NCT06800248	Swiss Tropical & Public Health Institute	Phase 3
Enrolling By Invitation	Efficacy and Safety of Emodepside in Participants With Soil-transmitted Helminth Infections NCT06736691	Swiss Tropical & Public Health Institute	Phase 3
Completed	Efficacy and Safety of Oxantel Pamoate in Children Infected With Trichuris Trichiura NCT06720259	Jennifer Keiser	Phase 2
Completed	Evaluating Impact of Improved Floors on Health NCT05914363	London School of Hygiene and Tropical Medicine	N/A
Completed	Na-GST-1/Alhydrogel With or Without CpG 10104 in Gabonese Adults NCT03373214	Baylor College of Medicine	Phase 1
Completed	Triple Combinations Against Hookworm Infections in Lao NCT03278431	Swiss Tropical & Public Health Institute	Phase 4
Completed	Study of Co-administered Na-APR-1 (M74) and Na-GST-1 in Gabonese Children NCT02839161	Baylor College of Medicine	Phase 1
Completed	Study of Na-APR-1 (M74)/Alhydrogel® Co-administered With Na-GST-1/Alhydrogel in Brazilian Adults NCT02476773	Baylor College of Medicine	Phase 1
Recruiting	Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm L NCT01940757	Baylor College of Medicine	Phase 1
Completed	Safety and Immunogenicity of Co-Administered Hookworm Vaccine Candidates Na-GST-1 and Na-APR-1 in Gabonese Adu NCT02126462	Baylor College of Medicine	Phase 1
Completed	Safety and Immunogenicity Study of Na-GST-1 With or Without CpG NCT02143518	Baylor College of Medicine	Phase 1
Unknown	Hookworm Immune Regulation Project NCT02262403	Brugmann University Hospital	N/A
Completed	Safety and Immunogenicity of the Na-APR-1 Hookworm Vaccine in Healthy Adults NCT01717950	Baylor College of Medicine	Phase 1
Completed	Safety and Immunogenicity of a Human Hookworm Candidate Vaccine With Different Doses of a Novel Adjuvant NCT01385189	Baylor College of Medicine	Phase 1
Completed	Safety and Immunogenicity of a Human Hookworm Candidate Vaccine With or Without Additional Adjuvant in Brazili NCT01261130	Baylor College of Medicine	Phase 1
Completed	Prevalence of Hookworm Infection and Community Preparedness for Hookworm Vaccine Trials in Endemic Areas of Br NCT00939198	Albert B. Sabin Vaccine Institute	N/A
Completed	Development of a Skin Test for the Na-ASP-2 Hookworm Antigen NCT00603889	Albert B. Sabin Vaccine Institute	N/A
Terminated	Phase 1 Trial of Na-ASP-2 Hookworm Vaccine in Previously Infected Brazilian Adults NCT00473967	Albert B. Sabin Vaccine Institute	Phase 1
Completed	Study of Na-ASP-2 Human Hookworm Vaccine in Healthy Adults Without Evidence of Hookworm Infection NCT00120081	Baylor College of Medicine	Phase 1
Completed	Effectiveness of Combined Albendazole and Ivermectin Treatment for Intestinal Worm Infections NCT00207753	Centers for Disease Control and Prevention	N/A